LEADER 03934nam 22006615 450 001 9910369937803321 005 20200630045147.0 010 $a3-030-27779-8 024 7 $a10.1007/978-3-030-27779-6 035 $a(CKB)4100000009522976 035 $a(DE-He213)978-3-030-27779-6 035 $a(MiAaPQ)EBC5942858 035 $a(PPN)248604511 035 $a(EXLCZ)994100000009522976 100 $a20191012d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRadiopharmaceuticals $eA Guide to PET/CT and PET/MRI /$fedited by Ferdinando Calabria, Orazio Schillaci 205 $a2nd ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (XII, 234 p. 193 illus., 184 illus. in color.) 311 $a3-030-27778-X 327 $a18F-FDG -- 18F-DOPA -- The lipogenesis pathway: radiolabeled choline -- 18F-FET -- 18F-NaF -- The Somatostatin Receptors Analogues (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE) -- 64Cu-radiopharmaceuticals -- Amyloid Imaging -- PET myocardial perfusion imaging: 82Rb -- The bone pathway: 223Ra-dichloride -- 11C-methionine -- 68Ga-PSMA -- PET biomarkers for tau pathology. 330 $aThis book provides a rapid and concise guide to PET (PET/CT and PET/MRI) molecular imaging, concentrating extensive information on PET radiopharmaceuticals in a single volume. The book reflects the rapid development of several PET tracers over the last decade, as a result of which the ?traditional? PET/CT with 18F-FDG, the ?cornerstone? of PET imaging, is now only one of several available options, which use different tracers for different diseases. For the same reason, PET imaging is no longer limited to the field of oncology. In the editors? experience, students in medicine and residents in nuclear medicine and radiology have limited access to scientific papers concerning novel PET tracers. Moreover, these papers generally focus on a single PET radiopharmaceutical. With approx. 20 radiopharmaceuticals explained in detail and a wealth of images and clinical cases, the book represents a versatile, comprehensive and practice-oriented guide to PET imaging, pursuing a unique and novel approach to the clinical role of PET tracers. The book?s didactic nature also makes it an invaluable tool for residents in nuclear medicine and radiology, as well as for radiographers and clinicians in radiotherapy, oncology, hematology, cardiology and neurology. 606 $aNuclear medicine 606 $aOncology   606 $aRadiotherapy 606 $aHematology 606 $aNeurology  606 $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 606 $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001 615 0$aNuclear medicine. 615 0$aOncology  . 615 0$aRadiotherapy. 615 0$aHematology. 615 0$aNeurology . 615 14$aNuclear Medicine. 615 24$aOncology. 615 24$aRadiotherapy. 615 24$aHematology. 615 24$aNeurology. 676 $a616.07548 676 $a616.07575 702 $aCalabria$b Ferdinando$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSchillaci$b Orazio$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369937803321 996 $aRadiopharmaceuticals$92291675 997 $aUNINA